
Axsome: One Step At A Time
koto_feja/E+ via Getty Images Intro Axsome Therapeutics' (NASDAQ:AXSM) progress continues to be slow and steady. While the initiation of labeling discussions with the FDA has forced the market to give AXS-05 some credit, its therapeutic and market …